MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$0.79
+0.09 (+13.00%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,768.5% upside
Low Target
$21.05
Average Target
$30.60
High Target
$40.98
Current Price
$0.79
Current
$0.79
$0.79
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Scenario Analysis
Bear Case
$21.05
2,561.2%
Low target
Base Case
$30.60
+3,768.5%
Avg target
Bull Case
$40.98
+5,080.8%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$2.01
-60.6% from high
52-Week Low
$0.60
+31.8% from low
50-Day SMA
$0.95
-16.7% vs SMA
200-Day SMA
$1.25
-36.7% vs SMA
RSI (14)
40.8
Neutral
Target vs 52W High
$30.60
+1,422.4% vs high
Next Earnings Report
Nov 18, 2026
3d
until earnings
EPS Est: $-0.65
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.7% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.8% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.6% |
| REGN | Buy | 36 | 72% | $76.80 | -92.0% |
| MRNA | Hold | 31 | 32% | $149.45 | -33.1% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.2% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -33.8% |